News Image

Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Executive Officer

Provided By GlobeNewswire

Last update: Jul 1, 2025

Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies

Career focused on driving business growth and developing an integrated commercial strategy to deliver results

Read more at globenewswire.com

OUTLOOK THERAPEUTICS INC

NASDAQ:OTLK (11/28/2025, 7:53:52 PM)

After market: 1.81 +0.02 (+1.12%)

1.79

+0.11 (+6.55%)



Find more stocks in the Stock Screener

OTLK Latest News and Analysis

Follow ChartMill for more